Contract Services Contract Research
Thermo Fisher Scientific Expands Access To Structural Biology With Glacios 3 Cryo TEM
Equipped with the READY System to make structural biology research accessible to more labs Thermo Fisher Scientific, the world leader in serving science, ...
April 01, 2026 | News
WuXi XDC Reports Strong 2025 Growth Driven By Bioconjugate Leadership And Expanding Global Footprint
Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 3...
March 25, 2026 | Company results
CellCarta And Biofidelity Expand Global Partnership With Exclusive Aspyre Lung Deployment In Clinical Trials
CellCarta and Biofidelity announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settin...
March 20, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
AtomVie Supplies First Patient Dose In Radiopharm Theranostics Phase 1 2a Study Of 177Lu BetaBart
AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first pat...
February 26, 2026 | News
Syngene Partners With Johns Hopkins To Accelerate Early Stage Drug Discovery
Syngene International, a global contract research, development, and manufacturing organization (CRDMO) announced a strategic collaboration with Johns Hopki...
February 13, 2026 | News
Thermo Fisher Scientific And Datavant Partner To Advance Connected Real World Evidence In Clinical Research
Thermo Fisher Scientific, the world leader in serving science,announced a strategic data collaboration with Datavant, the data collaboration platform trust...
February 12, 2026 | News
Lupin Launches Topiramate Extended Release Capsules In The United States
Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the launch of Topira...
February 06, 2026 | News
WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...
February 04, 2026 | News
Frontage Laboratories Expands Early Phase Clinical Research Capabilities Across The United States And China
Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the expansion of ...
February 03, 2026 | News
Fidēs Launches Science Led Imaging CRO Focused On Early Phase Clinical Decision Making
Fidēs announced its launch as a new imaging contract research organization (iCRO) designed specifically for early-phase clinical development, where imagin...
February 02, 2026 | News
HKeyBio Introduces Translational Preclinical Strategy To Rethink Asthma And Allergy Drug Development
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, announced a translational preclinical strategy, HKEY-AIRxTM1.0...
January 29, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
